FDA/CDC
FDA/CDC
FDA approves imaging drug for detecting ovarian cancer lesions
Drug inventor Philip Low, PhD, said the agent causes ovarian cancer lesions to “light up like stars against a night sky.”
FDA/CDC
FDA panel slams Endologix response to stent-graft safety issues
The company argued to skeptical advisors that upgrades to its AAA-repair system have already cut any potential endoleak risk, a long-running...
FDA/CDC
FDA class I recall of CardioSave hybrid/rescue IABPs
Subpar batteries were mistakenly released to a limited number of customers and may have a shortened run time and fail unexpectedly.
Latest News
FDA approves combo pill for severe, acute pain
Seglentis contains 56 mg of celecoxib and 44 mg of tramadol.
Latest News
CDC chief overrules panel, OKs boosters for health care workers
Panelists “did not buy the need in occupational or institutional settings.”
FDA/CDC
FDA OKs Pfizer COVID booster for 65 and over, those at high risk
Emerging evidence shows that booster doses of the Pfizer vaccine cause front-line immune defenders — called binding antibodies — to roughly triple...
FDA/CDC
FDA approves Abbott’s Portico valve for TAVR
The approval, based largely on the recently published PORTICO-IDE trial, is for patients with severe symptomatic aortic stenosis at ‘high or...
FDA/CDC
FDA panel backs Pfizer's COVID booster for 65 and older, those at high risk
This followed an earlier 16-2 vote by the panel rejecting a booster dose for Americans age 16 and over.
Latest News
New Moderna vaccine data ‘support’ booster shot after 8 months
There is still a lot of debate in the medical community about the need for boosters.
News from the FDA/CDC
CDC officially endorses third dose of mRNA vaccines for immunocompromised
Just hours after the FDA updated its EUA for COVID vaccines, the CDC has recommended a third dose for those who are at higher risk for severe or...
FDA/CDC
Heparin’s COVID-19 benefit greatest in moderately ill patients
A multiplatform trial reported that therapeutic heparin improved outcomes in moderately ill COVID-19 patients but not in critically ill patients...